Eliem Therapeutics, Inc. (ELYM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 278.71M |
| Enterprise Value | 243.56M |
| P/E Ratio | -14.68 |
| PEG Ratio | -0.32 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -14.68 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -0.31 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 97,000 |
| Net Income | -59.85M |
| Diluted EPS | -0.88 |
Balance Sheet
| Total Cash | 109.56M |
| Total Cash/Share | 1.61 |
| Total Debt | 479,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 27.86 |
| Book Value Per Share | 2.17 |
Price History
| 52-Week Change | 92.83 |
| 52-Week High | 11.55 |
| 52-Week Low | 2.35 |
| Moving Average 50 Days | 6.46 |
| Moving Average 200 Days | 5.57 |
Statistics
| Average Volume | 519,722 |
| Shares Outstanding | 67.06M |
| % Held by Institutions | 45.92 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
